Le Lézard
Classified in: Health
Subject: AWD

PharmaPoint Featured on RxInsider's Pharmacy500 List for 2024


PharmaPoint has been awarded a spot on RxInsider's 2024 Pharmacy500 List

BIRMINGHAM, Ala., April 3, 2024 /PRNewswire-PRWeb/ -- PharmaPoint has been awarded a spot on RxInsider's 2024 Pharmacy500 List, joining the ranks of other prominent organizations recognized for significantly impacting the country's pharmacy industry.

"The privilege of advocating for patient's medication treatment plans through the care continuum in order to help ensure members of high-risk populations are proactively engaged is what fuels our organization."

"We are honored to be included on this list," says Mike Plaia, PharmaPoint CEO. "The privilege of advocating for patient's medication treatment plans through the care continuum in order to help ensure members of high-risk populations are proactively engaged is what fuels our organization."

Inspired by the Fortune 500, the Pharmacy500 is a list of 500 companies and national associations that had a significant impact on dispensing pharmacies across the United States last year.

"From driving operational efficiencies to supporting exemplary patient care, the Pharmacy500 represents companies that are shaping the pharmacy landscape," says Greg Cianfarani, RPh, Founder and Chief Executive Officer for RxInsider. "We always strive to celebrate and recognize innovative products, services and companies across the pharmacy supply chain."

About PharmaPoint
PharmaPoint is an innovative, technology-enabled pharmacy management and software company. XchangePoint, our proprietary integrated workflow management system supporting medication management across care transitions, is designed for pharmacy and care team members to drive medication optimization for at-risk patients in the acute, post-acute and ambulatory care settings. Additionally, through the management of outpatient retail pharmacies for hospitals, health systems and physician groups, our commitment to completing the care continuum results in improved patient health and satisfaction, reduced healthcare costs, and provides clients with a source of ancillary income. Headquartered in Birmingham, Ala., PharmaPoint has been recognized as one of the most innovative, inspiring and fastest growing private companies for six consecutive years by Inc. Magazine. For more information about our company, please visit http://www.pharmapoint.com.

Media Contact

Elizabeth Shelton, PharmaPoint, 2059994167, [email protected], www.pharmapoint.com

SOURCE PharmaPoint


These press releases may also interest you

at 03:00
Recor Medical Champions Global Action on World Hypertension Day: Early Intervention and Continued Innovation Crucial in Tackling This Silent Killer Impacting Billions Worldwide
Hypertension, or high blood pressure, affects one in three Europeans over the age of 30 and more than one billion people worldwide.  Hypertension is known as the "silent killer" because many people do not know they have it and, over time, it can lead...

at 03:00
New Partnership Between Clean Cooking Alliance and World Resources Institute Seeks To Promote Clean Cooking in Key Regions
At the Summit on Clean Cooking in Africa, World Resources Institute (WRI) and the Clean Cooking Alliance (CCA) announced a strategic partnership to further embed clean cooking into a broad range of sustainable development initiatives across the two...

at 02:00
QuTEM Receives GMP Certificates and Manufacturing Permits for Transmission Electron Microscopy Laboratory from the Swedish Medical Products Agency
QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality...

at 01:54
RaySearch Laboratories: Interim report January 1 - March 31, 2024
FIRST QUARTER (JANUARY - MARCH 2024) Oder intake SEK 238.5 M (206.6)Net sales SEK 257.2 M (230.2)Operating profit SEK 45.8 M (23.7)Profit after tax SEK 36.7 M (17.6)Earnings per share before/after dilution SEK 1.07 (0.51)Cash flow SEK 87.9 M...

at 01:00
Luraco Technologies Introduces the New i9 Max Plus Series with Advanced Features for Ultimate Comfort and Therapeutic Massage
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA announces two-year data for ZYMFENTRAtm(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

More news about Health...


News published on and distributed by: